Abstract
The latest coronavirus pandemic, originated by the human coronavirus or SARS-CoV-2, has developed into a crucial global health affair over the past 2 years. These viruses are acclaimed to trigger a range of respiratory and enteric disorders in a diverse group of organisms and humans. Coronavirus have also been reported to cause respiratory failure, the complication of sepsis, and one or numerous organ failure. Several studies revealed that coronavirus-positive individuals had a liver injury. In those individuals, the increased levels of hepatic enzymes mainly AST and ALT and signs of inflammation were analyzed in complex clinical cases According to recent clinical data, abnormal levels of AST/ALT are more often noticed in coronavirus positive patients, but the fundamental pathogenesis is still not known entirely. We evaluated the current literature on COVID-19 and its effect on AST/ALT levels in coronavirus-positive patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Open Access Research Journal of Biology and Pharmacy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
